Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $19.80, but opened at $18.45. Ascentage Pharma Group International shares last traded at $18.61, with a volume of 10,088 shares.
Ascentage Pharma Group International Price Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Recommended Stories
- Five stocks we like better than Ascentage Pharma Group International
- Differences Between Momentum Investing and Long Term Investing
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What is a support level?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Trading Halts Explained
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
